MOHAMMED N AL HALLAK to Carcinoma, Pancreatic Ductal
This is a "connection" page, showing publications MOHAMMED N AL HALLAK has written about Carcinoma, Pancreatic Ductal.
Connection Strength
0.126
-
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers. Mol Cancer Ther. 2023 Dec 01; 22(12):1422-1433.
Score: 0.101
-
The phase I/II eNRGy trial: Zenocutuzumab in?patients with cancers harboring NRG1 gene fusions. Future Oncol. 2024; 20(16):1057-1067.
Score: 0.026